Skip to main content
NewslettersWatchlist
hello world

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Stocks in play: WELL Health Technologies Corp.

Baystreet.ca - Baystreet - Thu Nov 7, 8:56AM CST

Announced its interim consolidated financial results for the quarter ended September 30, 2024. WELL surpassed $1 billion annualized revenue run-rate with record revenue of $251.7 million in Q3-2024, marking a 27% increase compared to Q3-2023, mainly driven by organic growth of 23%. WELL achieved record Adjusted EBITDA of $32.7 million in Q3-2024, an increase of 16% as compared to Q3-2023.WELL Health Technologies Corp. shares T.WELL are trading up $0.22 at $4.74.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).